ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 113237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 113237; 2) Community: the network communities that were significantly associated with the response to NSC 113237; 3) Molecule: the relationships between components within communities and NSC 113237; 4) MDR: the compounds that were significantly associated with the NSC 113237.

NSC Compound Enrichment Correlation
NSC 638241 Null 0.00172065213317242 0.66797582
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.00172065213317242 0.42708341
NSC 669146 6,9-Epoxy-2H-1,4-dioxacyclodeca[cd]pentalene-2,7(4aH)-dione, 2a,3,5,6,11a,11b-hexahydro-3-hydroxy-2a,6,10-trimethyl-3-(1-methylethenyl)-, [2aS-(2aR*,3S*,4aR*,6S*,10Z,11aS*,11bS*)]- 0.00172065213317242 0.4965938
NSC 684901 Null 0.00172065213317242 0.42229565
NSC 733755 Null 0.00172065213317242 0.4095942
NSC 741898 4-(2-pyridinyl)-5H-1,2,3-dithiazole-5-thione 0.00172065213317242 0.46920211
NSC 109084 Null 0.00176785174089477 0.66188666
NSC 117281 ANTINEOPLASTIC-117281 0.00176785174089478 0.45722803
NSC 126771 Dichloroallyl lawsone 0.00176785174089478 0.52398587
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.00176785174089478 0.5517939
Total:136  Current:17    [First] [Prev] [Next] [Last]